The presence of disease-associated prions in tissues and bodily fluids of chronic wasting disease (CWD)-infected cervids has received much investigation, yet little is known about mother-to-offspring transmission of CWD. Our previous work demonstrated that motherto-offspring transmission is efficient in an experimental setting. To address the question of relevance in a naturally exposed free-ranging population, we assessed maternal and fetal tissues derived from 19 elk dam-calf pairs collected from free-ranging Rocky Mountain elk from north-central Colorado, a known CWD endemic region. Conventional immunohistochemistry identified three of 19 CWD-positive dams, whereas a more sensitive assay [serial protein misfolding cyclic amplification (sPMCA)] detected CWD prion seeding activity (PrP stage. These findings demonstrated that PrP CWD is more abundant in peripheral tissues of CWD-exposed elk than current diagnostic methods suggest, and that transmission of prions from mother to offspring may contribute to the efficient transmission of CWD in naturally exposed cervid populations.
INTRODUCTION
Transmissible spongiform encephalopathies (TSEs) are a class of surreptitious neurodegenerative diseases which have been recognized for almost a century, but only became prominent in the research spotlight during the bovine spongiform encephalopathy and subsequent variant Creutzfeldt-Jakob disease outbreaks in the 1980s and 1990s (Wells et al., 1991; Hill et al., 1997; Brown et al., 2001) . Many interesting and confounding aspects of TSEs have been revealed, such as the fact that the causative agent is a prion (Prusiner, 1982) , a misfolded, protease-resistant form (PrP res ) of a protein with nearly universal expression in the animal kingdom (PrP C ), and whose function is still elusive and controversial, despite the enormous body of research undertaken to reveal it (Aguzzi et al., 2008; Sakudo & Onodera, 2014) .
TSEs have long incubation periods, ranging from months to years, during which affected hosts harbour and shed infectious particles, despite absence of clinical signs (Gill et al., 2013; Lacroux et al., 2014) . Thus, infectious prions can be transmitted from excreta or body fluids (e.g. urine, faeces, saliva, blood) of live animals, as well as carcasses, to infect susceptible animals or contaminate environments and fomites (Brown et al., 2001; Mathiason et al., 2006; Nichols et al., 2009; Notari et al., 2010; Gilch et al., 2011; Saunders et al., 2012) . One distinctive feature of prions is that they are extremely resistant to degradation; therefore, environmental contamination is a serious concern.
Chronic wasting disease (CWD) is a TSE with unusually high transmission efficiency among cervids (Miller & Williams, 2004; Sigurdson & Aguzzi, 2007; Gilch et al., 2011) . As is the case in all prionopathies, the aberrant, disease-associated protein accumulates in the central nervous system (CNS) and other tissues, causing slow and progressive neurological damage, resulting in behavioral abnormalities, emacia-tion, loss of bodily functions and ultimately death (Williams & Miller, 2002) . Prior to 2000, CWD in free-ranging cervids was localized in Wyoming and Colorado in the USA, but new reports of CWD emerged from more distant states in the ensuing years (Joly et al., 2009) . To date, CWD it is the most widespread natural TSE, with prevalence rates of 1-30 % in white-tailed deer (Odocoileus virginianus), 1-13 % in elk (Cervus elaphus nelsoni) and up to 50 % in mule deer (Odocoileus hemionus) populations in certain regions of North America (Miller & Williams, 2004; Gilch et al., 2011; Saunders et al., 2012) . In some infected populations, CWD is a leading cause of cervid mortality and may negatively impact population dynamics (Dulberger et al., 2010; Sargeant et al., 2011) . Both clinically and preclinically infected cervids harbour sufficient infectious prions to efficiently transmit disease (Hill & Collinge, 2003; Bishop et al., 2013; Elder et al., 2013) . CWD can be transmitted by direct contact with infected animals, carcasses, bodily fluids, secretions or excreta (Mathiason et al., 2006; Saunders et al., 2012; Lacroux et al., 2014) , or indirectly through uptake of infectious material shed into the environment (Miller & Williams, 2004; Mathiason et al., 2006; Saunders et al., 2012) . As a result, CWD prions are in no short supply, cycling between the clinically or latently infected animals and the environment they inhabit. As prions retain infectivity for many years and environmental decontamination is unrealistic, it is unlikely that the CWD reservoir will be depleted once an environment is significantly contaminated (Saunders et al., 2012) . Therefore, it is crucial that we prevent movement of infectious prions from contaminated areas and that we understand ecosystem-level effects of having a contaminated environment, as well as the potential implications for public health.
Although TSEs are known as diseases of the CNS, extraneural organs expressing PrP C can also serve as sites of PrP res conversion and/or accumulation (Peralta & Eyestone, 2009) , including the peripheral nervous system, lymphatic system, skeletal muscle, reproductive tissues, gastrointestinal tract and excretory system (Race et al., 1998; Notari et al., 2010) . Recent advances in methodologies for the sensitive detection of disease-associated prions in tissues and bodily fluids, including serial protein misfolding cyclic amplification (sPMCA) and real-time quakinginduced conversion (RT-QuIC) (Saá et al., 2006; Haley et al., 2012) , have enhanced our ability to detect trace amounts of protease-resistant prions more readily than conventional methods such as immunohistochemistry (IHC) (Ironside et al., 2000; Spraker et al., 2009) . With the aid of sPMCA, we previously demonstrated that CWD mother-to-offspring transmission occurs in an experimentally infected cervid model (Reeves' muntjac deer) and is associated with a fourfold increase in stillbirth rates . Our findings were in agreement with studies confirming maternal transmission in other species, such as sheep, cattle, felids and mouse models (Castilla et al., 2005; Bencsik et al., 2009; Foster et al., 2013) . Here, we address two remaining questions regarding the covert prion persistence mechanisms in a naturally infected population: (1) are prions vertically transmitted from CWD naturally exposed elk dams to offspring in utero, and (2) if so, is there an association between vertical transmission and peripheral distribution of prions in dam tissues?
RESULTS sPMCA
In our efforts to detect the minute amounts of amplifiable prions present in fetal and maternal tissues, we used sPMCA, a highly sensitive and specific method of PrP res detection (Saá et al., 2006) , superior to both IHC and Western blotting of unamplified material. We proceeded to evaluate the probability of contamination in our technique, as well as the optimal number of rounds of amplification necessary and sufficient to demonstrate the presence of amplification-competent material in each sample.
In order to determine the sensitivity of PMCA in our laboratory, we performed PMCA using serial dilution of known CWD-positive elk brain (E2) which has been described in a previous publications (Nichols et al., 2009; Wyckoff et al., 2013) . In Fig. 1 (Fig. 2) .
Specificity was ascertained by performing 75 separate reactions, seven rounds each, using known laboratory-negative and E2-positive 10 % cervid brain homogenate controls. The negative and the positive rounds were blinded and run in parallel with the samples (w500 samples total); representative blots are included the relevant figures. We observed no spontaneous amplification in our negative controls, whereas positive controls always had detectable PrP CWD upon proteinase K digestion. Consequently, we determined that the specificity of sPMCA was 100 % and therefore we considered as positive any tissue with detectable PrP CWD in at least one of the three replicate reactions (w50.99 for 0.2|10 212 known positive and known negative brain dilutions).
As we determined above that specificity was maintained, but that sensitivity of detection was enhanced by performing seven rather than five round of PMCA (Fig. 1) , we therefore deemed it appropriate and necessary to examine our environmentally sourced samples using these parameters, because we anticipated that vertically transmitted prions, as reported elsewhere , are present in such minute amounts that detection may be difficult without appropriate amplification. As expected, Western blot detection of PrP CWD in several samples (e.g. umbilicus, intestine and uterus; Fig. 3 ) was only possible after seven rounds of sPMCA, whereas PrP CWD was not detected in these tissues after five rounds.
Maternal results
All 19 animals from the CWD endemic area of Colorado appeared clinically normal at the time of euthanasia, as judged by their body condition and absence of clinical CWD signs. Their CWD status was ascertained by conventional IHC (Monello et al., 2014) , which identified three of 19 dams CWD-positive in retropharyngeal lymph nodes (RLNs). Two of these dams were also obex-positive by IHC (Spraker et al., 2009) , while the third was IHC obex-negative (Spraker et al., 2009) , as shown in Table 1 .
To comprehensively map PrP CWD presence and distribution in free-ranging elk, we analysed by blinded sPMCA a variety of maternal tissues, which we classified into four main categories (Fig. 4a 5 and 7 shown). PrP CWD was not detected in a 10 % homogenate of E2 prior to sPMCA or after one round of sPMCA. After three and five rounds of E2 sPMCA, PrP CWD was detected at 10 26 . PrP CWD was detected at 10 212 following seven rounds of sPMCA. sPMCA controls (R7-and R7+) showed complete proteinase K (PK) digestion of negative elk brain homogenate (R7-) and proteinase K-resistant PrP CWD in E2 CWD-positive elk brain homogenate (R7+) (10 % homogenates, undiluted, round 7). Western blot controls (no sPMCA) showed complete proteinase K digestion of PrP in negative white-tailed deer brain homogenate and proteinase K-resistant PrP CWD in CWD-positive white-tailed deer brain homogenate (10 % homogenates, undiluted, no sPMCA).
A. Selariu and others
Our blinded sPMCA analysis corroborates the CWD status of CWD-positive elk determined by Monello et al. (2013) (Table 1) . Strikingly, we identified 12 additional positive dams, which had been classified as CWD-negative by conventional IHC in the previous study. The total number of sPMCA PrP CWD -positive dams was 15 of 19; seven positive in brain/obex sections (C), seven positive in one or more of the lymphoid tissues (L), 13 positive in reproductive tissues (R) and 13 positive in one or more secretory/excretory or other tissues (S) (Fig. 4a) . Representative Western blots of various blinded dam tissues after seven rounds of sPMCA are presented in Fig. 5 .
We found dams with deposition in all tissue categories analysed (C+L+R+S, n53), dams with peripheral distribution only (L+R+S, n52), and dams with CNS and secretory deposits only (C+S, n52) (Fig. 4b) . Additionally, we found one dam with deposition in all tissue categories except lymphoid organs (C+R+S, n51), one with deposition only in CNS, lymphoid and reproductive organs (C+L+R, n51), and another with deposition in lymphoid and reproductive tissues only (L+R, n51). All positive dams had either positive R or S tissues -onethird being positive in tissues exclusively outside the nervous and lymphatic systems (R+S, n55). The latter result is remarkable in that these five dams lacked detectable sPMCA PrP CWD in any of the C or L tissues, which would typically be assessed for diagnostic purposes. Moreover, three of these dams had foetuses with one positive tissue, suggesting that lymphoid or nervous system deposition may not be required for in utero transmission.
Fetal results
None of the fetal tissues collected from five elk fetuses from the south-western portion of North Dakota tested positive for CWD using blinded sPMCA as described above. In fetal tissues collected from the CWD endemic region of Colorado, seven of 19 showed no evidence of CWD using blinded sPMCA. Four were collected from sPMCA-negative dams, while the other three were collected from dams with at least one sPMCA-positive tissue. All PrP CWD -positive elk fetuses (12 of 19) were carried by sPMCA-positive dams. Three of the positive fetuses were in early gestation, whilst the remaining nine were in midgestation. While most fetuses had only one or two tissues positive (Table 1) , one fetus had five (vagus nerve, spleen, colon, thymus and liver). Its dam was sPMCApositive in all four categories (C+L+R+ S, 10 of 18 tissues positive), but was negative by conventional IHC in the previous study (Monello et al., 2013) . Conversely, another elk dam -positive in all categories by sPMCA (C+L+ R+S, 14 of 18 tissues positive) and who had also been diagnosed as advanced CWD by IHC -had a mid-gestation fetus with only one tissue (colon) positive by sPMCA. The dam with no CNS positivity by either IHC or sPMCA, but with IHC-positive RLNs and sPMCA-positive L+R+S, was carrying a mid-gestation fetus with positive liver and RLNs. We also detected sPMCA PrP CWD in the umbilicus (n57) and placentomes (n57) of free-ranging elk. Representative Western blots of various blinded fetal tissues after seven rounds of sPMCA are presented in Fig. 6 .
DISCUSSION
The prevalence of CWD in elk in this study area was previously estimated at 12.9 % based on IHC results of RLNs and obex (Monello et al., 2013) , but 18.90 % by sPMCA (Wyckoff et al., 2015) . Monello et al. (2014) predicted that, under current population conditions, declines in this herd would occur if CWD prevalence exceeded 13 %. As IHC proved highly specific in the above studies, but insufficiently sensitive to detect CWD in subclinical individuals (Haley et al., 2012; Wyckoff et al., 2015) , we attempted to evaluate the previously unobservable CWD burden in these animals by examining additional tissues and also to determine the potential for in utero transmissibility.
Overall, blinded sPMCA was capable of detecting fivefold more PrP CWD -positive dams, bringing the percentage of subclinical carriers in our sample to 79 %. Had we decided Groups of 10 mice were inoculated intracranially with the E2 isolate of CWD prions diluted into normal brain homogenate at the indicated serial dilutions. End-point prion titres were determined as described previously (Reed & Muench, 1938 Additionally, as CWD affects elk of reproductive age, we aimed to investigate whether the pathogenic protein could be found in the fetuses of the euthanized cows. We show here that the majority of the positive dams (13 of 15) had positive reproductive tissues and 12 of 15 positive dams had positive fetuses. Seven positive dams had detectable PrP CWD in the umbilical cord. Spiropoulos et al. (2014) found that in utero infected domestic sheep lambs harbour most infectious material in the umbilical cord. In our study, all fetuses with positive umbilical cords harboured PrP CWD in at least one tissue; however, only five of seven elk dams with positive placentomes had positive fetuses. This latter observation is perplexing, but not without precedent; for example, in some pregnant Creutzfeldt-Jakob disease patients, PrP CJD was demonstrated in placental tissue, but not in the neonate (Di Gangi et al., 2015) . The seemingly arbitrary PrP CWD distribution pattern in elk fetuses may be more closely related to PrP C expression subtleties, including timing of PrP C expression during normal developmental biology (Peralta et al., 2012) , rather than to the dynamics of prion infection and dissemination as seen in adults. As the fetus may be exposed throughout gestation to maternal influx of prions via blood, placental transport or recycling of amniotic fluid (Wooding et al., 1997) , and because PrP C isoforms expressed on most fetal cells (Peralta et al., 2012) can serve as docking or conversion scaffolds for prions (Makzhami et al., 2014) , it is possible for PrP CWD to be found on virtually any tissue once the fetal-maternal barrier is crossed. Whether these prions had the potential to replicate efficiently in the fetal tissues cannot be ascertained nor whether they would have led to clinical disease at any time post-birth. A definitive pattern of transmissibility or tissue susceptibility cannot be deduced at this time due to sample limitations; however, it seems plausible that vertical transmission of CWD in free-ranging animals is an additional mechanism of prion persistence within cervid populations. An interesting further study would be to determine whether subclinical infections can occur across generations without eventually developing clinical disease.
In vitro diagnostic tests can be confusing because results may not always equal clinical disease. A similar puzzling phenomenon has been recognized for variant Creutzfeldt-Jakob disease, for which disease exposure estimates using appendix and tonsil IHC of exposed population samples were strikingly higher than the clinical variant Creutzfeldt-Jakob disease cases recorded (Gill et al., 2013) . One explanation for this discrepancy is that the prion infectivity threshold for the CNS is higher than that for the lymphoreticular system or peripheral organs (Béringue et al., 2012) . Thus, an outstanding question remains: are there obscure mechanisms by which latent prions are peripherally maintained in the susceptible host population but never develop into clinical disease?
In the case of CWD, current conventional detection methods such as IHC identify a small fraction of carriers in free-ranging elk populations. By contrast, we show that peripheral PrP CWD in free-ranging animals classified as negative by conventional means is demonstrable using A. Selariu and others a highly sensitive and specific detection assay (sPMCA). As 15 of the 19 dams analysed were positive in at least one tissue, we calculated the estimated PrP CWD prevalence in the CWD endemic group to be 70.5 %. This number may seem alarming, because the previously reported disease prevalence was close to 13 % (Monello et al., 2013) . Worthy of note here is that, even if we had applied a highly stringent filter to our data and considered as positive only samples which had detectable PrP CWD at least half the times run, and from which at least two homogenates were made and proved positive, 12 of the 19 dams would still have been positive and of these half were carrying fetuses which harboured proteinase K-resistant prions (Table S1 , available in the online Supplementary material). The fact that minute amounts of amplifiable and proteinase K-resistant material can be found in various organs, bodily fluids and secretions of free-ranging elk (current work and Saunders et al., 2012) suggests that CWD prions are harboured by these animals in more tissues and in patterns more unpredictable than anticipated. However, we must stress that this overwhelming proportion of PrP CWD positivity in the CWD endemic cohort reflects merely the presence of amplifiable protease-resistant material in various tissues and does not necessarily indicate these animals will develop clinical disease. Therefore, the significance of this discovery in relation to definitive disease is limited to speculation. Additional longitudinal studies in experimental animals need to be performed in order to address the correlation between PrP CWD accumulation in tissues of asymptomatic elk and the resulting clinical outcomes.
We also performed sequencing analysis of the PRNP gene to investigate the role of codon 132 polymorphism genetics in vertical transmissibility of CWD (Table 1) 
Ovary (4) Uterus (5) RAMALT (3) Umbilicus (7) Pancreas (2) Mammary gland (2) Ureter (4) Adipose tissue (5) Nasal epithelium (5) Bladder (5) Placentome (7) Salivary gland (4) Secretory/ excretory/other (S) n=13
Kidney (6) Tongue ( Total dams with at least one C tissue positive, n57; total dams with at least one L tissue positive, n57; total dams with at least one R tissue positive, n513; and total dams with at least one S tissue positive, n513. CT, cotyledon; K, kidney; LNG, lung; LVR, liver; MG, mammary gland; NE, nasal epithelium; OB, obex; OV, ovary; PA, pancreas; PL, placenta; RLN, retropharyngeal lymph node; SG, salivary gland; SP, spleen; TO, tongue; UR, ureter; UT, uterus.
Detection of sPMCA PrP
CWD in elk that test IHC-negative reiterates concerns that currently used diagnostic tests for CWD, whilst useful research tools, cannot be relied upon to detect all animals harbouring CWD prions (Monello et al., 2013; Wyckoff et al., 2015) . These subclinically infected animals may serve as a mode of transmission of CWD across the landscape. Our current discovery lends a better understanding of the extent of PrP CWD distribution in tissues of elk from a CWD endemic area and to the possibility of vertical transmission in asymptomatic cervids. Furthermore, it underscores that IHC results should not be interpreted as a safety test for food for human consumption. Additional applications of highly sensitive and specific assays such as sPMCA in experimental and natural environments will help refine our understanding of prion disease epidemiology, ecology and management.
METHODS
Elk tissue origin and handling. This study was performed in parallel with two other studies investigating the effects of CWD in an elk population in north-central Colorado with a long history of CWD exposure and clinical disease (Monello et al., 2013 (Monello et al., , 2014 . Nineteen whole elk fetuses were collected from elk dams euthanized during early (v12 weeks) and mid-(12-25 weeks) gestation. Corresponding tissues were collected from the dams. For comparison, control tissues were collected from the fetuses of pregnant elk culled in the southwestern part of North Dakota, a region where CWD is not known to occur. Fetuses were bagged and frozen shortly after the time of death, and then transported to Colorado State University. After thawing, tissues were harvested using single-use, animal-and tissue-specific blades and forceps to prevent cross-contamination, as previously described . The following tissues were collected from each fetus: brain, vagus nerve, spleen, colon, ileum, rectum, RLN, popliteal lymph node, thymus, liver and lung. Similarly, the following maternal tissues were collected: brain at the level of the obex (CNS: 'C'); spleen, RAMALT and RLNs (lymphoreticular system: 'L'); uterus, ovary, placentome and umbilical cord (reproductive system: 'R'); salivary gland, mammary gland, pancreas, kidney, urinary bladder, ureter, nasal epithelium, tongue and adipose tissue (secretory/excretory/other: 'S'). Tissues were then homogenized at 2-10 % (w/v) in cold, sterile 0.1 M PBS containing 0.1 % Triton-X, using 0.5 mm zirconium oxide beads in a BBX24B Bullet Blender Blue homogenizer (NextAdvance). All samples were coded, double-blinded and then subjected to sPMCA as described previously . Sample identities were not revealed until after all analyses were completed. A 10 % normal brain homogenate (NBH) in 0.1 M PBS buffer (pH 7.5, with 1 % Triton X-100) was prepared from whole brains collected from clinically healthy cervidized transgenic 5037 mice expressing normal levels of brain PrP cervid-elk (Tg CerPrP-E226 5037, up to 4 months old) to serve as a substrate for the PrP C -to-PrP CWD seeded conversion reaction in sPMCA. Slight modifications were made to the previously described procedure. Briefly, 30 ml elk tissue homogenate was added to 50 ml 10 % (w/v) NBH and subjected to seven 24 h rounds of sonication. Each round of sPMCA equals 288 cycles of 10 s sonication/5 min incubation at 37 uC (Misonix). After each round, 30 ml amplified material was transferred to 0.2 ml PCR tubes containing 50 ml 10 % NBH, and two 2.38 mm and three 3.15 mm Teflon beads (McMaster-Carr). Whenever tissue availability permitted it, each tissue was sampled three times and the homogenates thus prepared were individually amplified by sPMCA. When the quantity of tissue was limited (i.e. fetal tissues), one homogenate was obtained and subjected to sPMCA three separate times. PrP res presence was ascertained upon proteinase K digestion and subsequent visualization by Western blotting using an anti-cervid PrP antibody BAR-224 (Cayman Chemical) conjugated to HRP.
Western blotting. The seventh round of the sPMCA reaction was subjected to Western blotting as described previously . Briefly, known laboratory controls, and unamplified and amplified samples from CWD endemic and non-endemic areas were mixed with proteinase K (Invitrogen) for a 20 mg ml 21 final concentration and incubated at 37 uC for 30 min, followed by an additional 10 min at 45 uC with shaking. Samples were mixed with Reducing Agent (10|)/LDS Sample Buffer (4|) (Invitrogen) as per the manufacturer's instructions, heated to 95 uC for 5 min and then run through a 12 % Bistris gel at 100 V for 2 h. Proteins were transferred to a PVDF membrane in a Trans-Blot Turbo Transfer System (Bio-Rad). The membrane was blocked with Casein TBS Blocking buffer (Thermo Scientific) and probed with BAR-224 antibody as described above, and then developed with ECL Plus Western blotting Detection Reagents (GE) and viewed with an ImageQuant LAS-4000 (GE). Sample identities were revealed after blotting.
Prion inoculation into mice. Mice were inoculated intracranially as described previously (Meyerett et al., 2008) . Briefly, isofluorane anaesthetized mice were inoculated with 30 ml brain homogenate intracerebrally 3 mm deep through the coronal suture 3-5 mm lateral of the sagittal suture. Onset of clinical disease was measured by scoring mice from normal (0) to exhibiting terminal clinical signs (w9) as described previously (Wyckoff et al., 2013) .
